Exa Corp (NYSE:EXA) CFO Stephen Sarno acquired 1,000 shares of Exa Corp stock in a transaction dated Thursday, April 10th. The shares were purchased at an average price of $11.98 per share, for a total transaction of $11,980.00. Exa Corp (NASDAQ:EXA) shares after opening at $11.98 moved to $12.18 on last trade day and at the end of the day closed at $11.81. Company price to sales ratio in past twelve months was calculated as 2.89 and price to cash ratio as 5.47. Exa Corp (NASDAQ:EXA) showed a negative weekly performance of -2.07%.
The Wet Seal, Inc (NASDAQ:WTSL) Director Adam Rothstein bought 20,000 shares of The Wet Seal stock in a transaction that occurred on Monday, April 14th. The Wet Seal, Inc. (NASDAQ:WTSL) shares advanced 3.45% in last trading session and ended the day on $1.17. WTSL return on equity ratio is recorded as -35.30% and its return on assets is -18.10%. The Wet Seal, Inc. (NASDAQ:WTSL) yearly performance is -62.0%.
General Moly (NYSE:GMO) VP R Scott Roswell bought 11,000 shares of the company’s stock in a transaction dated Thursday, April 10th. The shares were purchased at an average price of $0.91 per share, for a total transaction of $10,010.00. General Moly, Inc. (NYSEMKT:GMO) shares moved up 4.72% in last trading session and was closed at $1.11while trading in range of $1.05 – $1.11- General Moly, Inc. (NYSEMKT:GMO) year to date (YTD) performance is -17.16%.
OHR Pharmaceutical (NASDAQ:OHRP) Director June Sherie Almenoff acquired 5,500 shares of OHR Pharmaceutical stock in a transaction dated Tuesday, April 8th. OHR Pharmaceutical Inc (NASDAQ:OHRP) weekly performance is -10.98%. On last trading day company shares ended up $9.32. OHR Pharmaceutical (NASDAQ:OHRP) distance from 50-day simple moving average (SMA50) is -36.41%. Analysts mean target price for the company is $21.00.